Moreover, despite the fact that BA levels in the intestine and tumor tissues have not been measured, the decrease of circulating BAs and modulation of their composition is responsible for the observed Fxr-dependent anti-tumorigenic capacity. Here, NR1H4 is linked to neoplasm.